[ CARB-X - Non-traditional approaches to combating antibiotic resistant bacteria | Research funding ]
Event details
| Date | 10.06.2019 |
| Category | Call for proposal |
Aim: CARB-X welcomes applications from around the world for funding and support for the early development of antibiotics, diagnostics, vaccines and other products to combat the most serious drug-resistant bacteria. The goal is to support them through the early stages of product development and Phase 1 so they can attract private or public investment for further clinical stage development.
Round 1 for this program focuses on Non-traditional approaches. These include:
For antibiotics and other therapeutics, CARB-X funds projects from Hit-to-Lead into Phase 1.
Funding: Project dependent.
Duration: Project dependent.
Eligibility: CARB-X welcomes applications from around the world. Applicants must have a legal entity. Product developers (PDs) must have appropriate operations or capabilities in place to support product development, particularly through the development stages in scope for CARB-X.
How to Apply: There is a three-step application process. First, an Expression of Interest (EOI) must be submitted summarizing the product proposed as a candidate for support. EOIs are submitted on the application portal. Selected applicants then move to the second step, in which selected companies submit a confidential Short Form. Finally, in a third step selected applicants submit a Long Form and detailed budget.
EOI Deadline: 10 June 2019
Further information
Round 1 for this program focuses on Non-traditional approaches. These include:
- Indirect acting small molecules (virulence, potentiators, BLI combinations etc.)
- Direct- and indirect-acting large molecules (peptides, etc.)
- Phage
- Microbiome
- Nucleic acid/anti-sense
- Drug conjugates (ADC, other dual acting drug conjugates)
For antibiotics and other therapeutics, CARB-X funds projects from Hit-to-Lead into Phase 1.
Funding: Project dependent.
Duration: Project dependent.
Eligibility: CARB-X welcomes applications from around the world. Applicants must have a legal entity. Product developers (PDs) must have appropriate operations or capabilities in place to support product development, particularly through the development stages in scope for CARB-X.
How to Apply: There is a three-step application process. First, an Expression of Interest (EOI) must be submitted summarizing the product proposed as a candidate for support. EOIs are submitted on the application portal. Selected applicants then move to the second step, in which selected companies submit a confidential Short Form. Finally, in a third step selected applicants submit a Long Form and detailed budget.
EOI Deadline: 10 June 2019
Further information
- More details on the call can be found on the application website.
- A pre-recorded webinar explaining the 2019 calls can be found here.
- For any other questions, contact the Research Office.
Practical information
- General public
- Free